|
CDXS
|
Codexis, Inc.
|
0.12%
|
US
|
NASDAQ
|
|
TSVT
|
2seventy bio, Inc.
|
0.11%
|
US
|
NASDAQ
|
|
TCMD
|
Tactile Systems Technology, Inc.
|
0.11%
|
US
|
NASDAQ
|
|
PGEN
|
Precigen, Inc.
|
0.11%
|
US
|
NASDAQ
|
|
FATE
|
Fate Therapeutics, Inc.
|
0.11%
|
US
|
NASDAQ
|
|
BFLY
|
Butterfly Network, Inc.
|
0.11%
|
US
|
NYSE
|
|
ATRA
|
Atara Biotherapeutics, Inc.
|
0.11%
|
US
|
NASDAQ
|
|
AMRX
|
Amneal Pharmaceuticals, Inc.
|
0.11%
|
US
|
NYSE
|
|
STOK
|
Stoke Therapeutics, Inc.
|
0.10%
|
US
|
NASDAQ
|
|
RIGL
|
Rigel Pharmaceuticals, Inc.
|
0.10%
|
US
|
NASDAQ
|
|
OCUL
|
Ocular Therapeutix, Inc.
|
0.10%
|
US
|
NASDAQ
|
|
ACET
|
Adicet Bio, Inc.
|
0.10%
|
US
|
NASDAQ
|
|
ZIMV
|
ZimVie Inc.
|
0.09%
|
US
|
NASDAQ
|
|
OCGN
|
Ocugen, Inc.
|
0.09%
|
US
|
NASDAQ
|
|
LUNG
|
Pulmonx Corporation
|
0.09%
|
US
|
NASDAQ
|
|
KPTI
|
Karyopharm Therapeutics Inc.
|
0.09%
|
US
|
NASDAQ
|
|
KNTE
|
Kinnate Biopharma Inc.
|
0.09%
|
US
|
NASDAQ
|
|
HRTX
|
Heron Therapeutics, Inc.
|
0.09%
|
US
|
NASDAQ
|
|
AADI
|
Aadi Biosciences, Inc.
|
0.09%
|
US
|
NASDAQ
|
|
KALV
|
KalVista Pharmaceuticals, Inc.
|
0.08%
|
US
|
NASDAQ
|